MedTrace Logo

Self-efficacy Coaching for Women With Breast Cancer

NCT03478384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2022-10-27

No results posted yet for this study

Summary

This is an open, prospective, multi-center, interventional study to evaluate the benefit and efficacy of individualized self-efficacy coaching for women with high-risk early breast cancer.

In total, 6 sites will be assigned 1:1 to either the experimental arm (Group A) or the control arm (Group B). The controlled site assignment will assure a balanced site-specific QoL between both groups at baseline. All patients will be medically treated according to guidelines. The experimental Group A will in addition receive regular self-efficacy coaching.

Conditions

Interventions

BEHAVIORAL

Patient coaching

Patients receive regular coaching to test if the coaching alters their perceived self-efficacy.

Sponsors & Collaborators

  • iOMEDICO AG

    collaborator INDUSTRY

  • Stiftung Patientenkompetenz

    lead OTHER

Principal Investigators

  • Gerd Nagel, Professor MD · Stiftung Patientenkompetenz

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-16
Primary Completion
2018-11-22
Completion
2018-11-22

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03478384 on ClinicalTrials.gov